• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泰国人群中针对 H7N9 和 H5N1 禽流感病毒的交叉反应性抗体。

Cross-reactive antibodies against H7N9 and H5N1 avian influenza viruses in Thai population.

机构信息

Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University.

Center of Research and Innovation, Faculty of Medical Technology, Mahidol University.

出版信息

Asian Pac J Allergy Immunol. 2017 Mar;35(1):20-26. doi: 10.12932/AP0788.

DOI:10.12932/AP0788
PMID:27543728
Abstract

BACKGROUD

Avian influenza H5N1 and H7N9 viruses have jumped across species from avian to humans and become a threat to public health. Not much is known about pre-existing cross-reactive antibodies against these avian viruses in human population.

OBJECTIVE

To determine the prevalence of cross-reactive anti-HA and anti-NA antibodies to avian influenza H5N1 and H7N9 viruses in Thai population.

METHOD

Archival serum samples from 100 blood donors and 21 patients infected with 2009 pandemic influenza A (H1N1) (pdmH1N1) virus were investigated by hemagglutination-inhibition (HAI) and neuraminidase-inhibition (NAI) assays for anti-HA and anti-NA antibodies, respectively. The test antigens comprised 2 human viruses (pdmH1N1 and H3N2 viruses), and 6 reassortant viruses carrying HA and NA genes of avian H5N1 or H7N9 virus generated by reverse genetics.

RESULTS

HAI antibody titers ≥ 10 were found in 58, 89, 0 and 15% of blood donors as tested against pdmH1N1, H3N2, H5N1 and H7N9 viruses, respectively. On the other hand, NAI antibodies were detected in 98, 94, 73 and 53% of blood donors when reverse genetic-derived viruses harboring NA gene from pdmH1N1, H3N2, H5N1 or H7N9 virus were used as the test antigens. Moreover, 66.7% of pdmH1N1 patients who had > 4 fold increase in HAI antibody titers in paired sera developed > 4 fold increase in NAI antibody titers.

CONCLUSIONS

Anti-NA antibody has broader reactivity than anti-HA antibody, therefore, it can be a supplement to anti-HA antibody in the prevention against novel influenza viruses.

摘要

背景

禽流感 H5N1 和 H7N9 病毒已经从禽类跨越物种传播到人类,并对公共卫生构成威胁。目前对于人类群体中针对这些禽流感病毒是否存在预先存在的交叉反应性抗体知之甚少。

目的

确定泰国人群中针对禽流感 H5N1 和 H7N9 病毒的交叉反应性抗 HA 和抗 NA 抗体的流行率。

方法

通过血凝抑制(HAI)和神经氨酸酶抑制(NAI)试验分别检测来自 100 名献血者和 21 名感染 2009 年大流行性流感 A(H1N1)(pdmH1N1)病毒患者的存档血清样本中的抗 HA 和抗 NA 抗体。测试抗原包括 2 种人类病毒(pdmH1N1 和 H3N2 病毒)以及通过反向遗传学产生的携带禽流感 H5N1 或 H7N9 病毒的 HA 和 NA 基因的 6 种重配病毒。

结果

在针对 pdmH1N1、H3N2、H5N1 和 H7N9 病毒的检测中,献血者的 HAI 抗体滴度≥10 的比例分别为 58%、89%、0%和 15%。另一方面,当使用携带 pdmH1N1、H3N2、H5N1 或 H7N9 病毒的 NA 基因的反向遗传衍生病毒作为测试抗原时,在 98%、94%、73%和 53%的献血者中检测到 NAI 抗体。此外,在配对血清中 HAI 抗体滴度增加 4 倍以上的 66.7%的 pdmH1N1 患者中,NAI 抗体滴度也增加了 4 倍以上。

结论

抗 NA 抗体的反应性比抗 HA 抗体更广泛,因此,它可以作为预防新型流感病毒的抗 HA 抗体的补充。

相似文献

1
Cross-reactive antibodies against H7N9 and H5N1 avian influenza viruses in Thai population.泰国人群中针对 H7N9 和 H5N1 禽流感病毒的交叉反应性抗体。
Asian Pac J Allergy Immunol. 2017 Mar;35(1):20-26. doi: 10.12932/AP0788.
2
Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.用H5N1和甲型H1N1大流行性流感病毒的重组神经氨酸酶蛋白免疫引发的交叉反应性神经氨酸酶抑制抗体。
J Virol. 2015 Jul;89(14):7224-34. doi: 10.1128/JVI.00585-15. Epub 2015 May 6.
3
A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.一种复制缺陷型流感病毒,同时携带 H5 和 H7 血凝素,可在小鼠中预防 H5N1 和 H7N9 感染。
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.02154-20.
4
Induction of H7N9-Cross-Reactive Antibody-Dependent Cellular Cytotoxicity Antibodies by Human Seasonal Influenza A Viruses that are Directed Toward the Nucleoprotein.人季节性甲型流感病毒诱导针对核蛋白的H7N9交叉反应性抗体依赖性细胞毒性抗体
J Infect Dis. 2017 Mar 1;215(5):818-823. doi: 10.1093/infdis/jiw629.
5
Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.流感 H7N9 病毒样颗粒(VLP)疫苗的研制:同源 A/Anhui/1/2013(H7N9)保护和异源 A/鸡/哈利斯科/CPIA1/2012(H7N3)对接种疫苗的小鼠用 H7N9 病毒攻毒的交叉保护作用。
Vaccine. 2013 Sep 13;31(40):4305-13. doi: 10.1016/j.vaccine.2013.07.043. Epub 2013 Jul 26.
6
Kinetics, Longevity, and Cross-Reactivity of Antineuraminidase Antibody after Natural Infection with Influenza A Viruses.甲型流感病毒自然感染后抗神经氨酸酶抗体的动力学、寿命及交叉反应性
Clin Vaccine Immunol. 2017 Dec 5;24(12). doi: 10.1128/CVI.00248-17. Print 2017 Dec.
7
Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.神经氨酸酶抑制抗体滴度与对同一神经氨酸酶亚型的异源流感病毒株的保护作用相关。
J Virol. 2018 Aug 16;92(17). doi: 10.1128/JVI.01006-18. Print 2018 Sep 1.
8
Generation and Characterization of Monoclonal Antibodies Specific to Avian Influenza H5N1 Hemagglutinin Protein.针对禽流感H5N1血凝素蛋白的单克隆抗体的产生与特性分析
Monoclon Antib Immunodiagn Immunother. 2015 Dec;34(6):436-41. doi: 10.1089/mab.2015.0047.
9
Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.灭活H7流感病毒疫苗尽管仅诱导产生低水平的中和抗体,但仍可保护小鼠。
J Virol. 2017 Sep 27;91(20). doi: 10.1128/JVI.01202-17. Print 2017 Oct 15.
10
Hemagglutinin amino acids related to receptor specificity could affect the protection efficacy of H5N1 and H7N9 avian influenza virus vaccines in mice.与受体特异性相关的血凝素氨基酸可能会影响H5N1和H7N9禽流感病毒疫苗对小鼠的保护效果。
Vaccine. 2016 May 17;34(23):2627-33. doi: 10.1016/j.vaccine.2016.03.031. Epub 2016 Apr 12.

引用本文的文献

1
Anti-neuraminidase immunity in the combat against influenza.抗神经氨酸酶免疫在抗击流感中的作用。
Expert Rev Vaccines. 2024 Jan-Dec;23(1):474-484. doi: 10.1080/14760584.2024.2343689. Epub 2024 Apr 23.
2
Kinetics, Longevity, and Cross-Reactivity of Antineuraminidase Antibody after Natural Infection with Influenza A Viruses.甲型流感病毒自然感染后抗神经氨酸酶抗体的动力学、寿命及交叉反应性
Clin Vaccine Immunol. 2017 Dec 5;24(12). doi: 10.1128/CVI.00248-17. Print 2017 Dec.